Chengdu Huasun Technology Group Inc., Ltd. (000790)

Overview

Chengdu huasun technology group Inc., LTD., rooted in the vibrant city of Chengdu, China, has carved its niche in the pharmaceutical and building industries since its inception in 1988. Originally established as Chengdu Taihe Health Technology Group Inc., Ltd., the company underwent a rebranding in April 2020, assuming its current name to better reflect its diversified interests and expansive vision. Its operational spectrum is broad, encompassing the manufacture and sale of a wide array of medical and bio-pharmaceutical products, alongside a dedicated division for the design, production, installation, and servicing of steel structure buildings. The blend of traditional and modern therapeutic solutions alongside engineering expertise outlines the unique business model of Chengdu huasun technology group Inc., LTD., highlighting its commitment to innovation and excellence.

Products and Services

Medicinal and Pharmaceutical Products: Chengdu huasun technology group Inc., LTD. is recognized for its comprehensive range of healthcare products. This includes:

• Modern Chinese Medicines and Chinese Patent Medicines: Leveraging the rich heritage of traditional Chinese medical practices, the company manufactures modern interpretations of classic remedies. These encompass a wide range of conditions and diseases, focusing on holistic wellness and natural ingredients.
• Chemical Medicines and Drugs: Recognizing the need for more conventional therapeutic solutions, the company also dedicates a significant portion of its operations to the development and production of chemical-based medicines. This division ensures a full spectrum of health care offerings, from antibiotics to chronic disease management drugs.
• Biological Products and Biotechnology Drugs: At the cutting edge of its pharmaceutical endeavors, the company engages in extensive research and development. This effort is specifically aimed at innovating biotechnology drugs, with a strong emphasis on treatments for cardiovascular and cerebrovascular diseases. The focus here is on pioneering biologically-based therapies that can offer new hope and solutions to patients worldwide.

Steel Structure Buildings: Complementing its pharmaceutical ventures, Chengdu huasun technology group Inc., LTD. also operates in the construction sector, specifically focusing on:

• Design, Production, Installation, and Services: The company possesses considerable expertise in creating steel structures for buildings. This service encompasses the entire process from design and production to installation and aftercare, ensuring high-quality, durable, and aesthetically pleasing structures for various uses, from industrial to commercial and residential buildings.